USANA director sells 2,450 shares in open market

USANA Health Sciences director John Turman Fleming sold shares in the company.

Rhea-AI Filing Summary

USANA Health Sciences director John Turman Fleming sold shares in the company. He completed an open-market sale of 2,450 shares of USANA common stock at a price of $17.93 per share. After this transaction, he directly holds 4,230 shares, indicating he retains a meaningful personal stake in the company despite the sale.

Insights

Insider trading analyst

USANA director executes a moderate open-market share sale.

Director John Turman Fleming sold 2,450 shares of USANA Health Sciences common stock in an open-market transaction at $17.93 per share. The transaction is coded as an open-market sale, a direct, discretionary move rather than a mechanical tax or grant event.

Following the sale, he directly holds 4,230 shares. This means he reduced but did not exit his position, keeping ongoing equity exposure. No derivative positions are reported, so the filing reflects straightforward common-stock ownership without options or similar instruments visible here.

With a single sale and no indication of a trading plan in the provided data, this appears as an isolated net-sell event. Subsequent filings may provide additional context if he continues to adjust his holdings over future reporting periods.

Insider Trade Summary

Net Seller: 2,450 shares

Net Sell 1 txn

Insider Fleming John Turman

Role Director

Sold 2,450 shs ($44K)

Type	Security	Shares	Price	Value
Sale	Common Stock	2,450	$17.93	$44K

Holdings After Transaction: Common Stock — 4,230 shares (Direct)

Key Figures

Shares sold: 2,450 shares Sale price per share: $17.93 per share Shares held after sale: 4,230 shares +1 more

4 metrics

Shares sold 2,450 shares Open-market sale of common stock

Sale price per share $17.93 per share Price for the 2,450-share sale

Shares held after sale 4,230 shares Direct ownership following transaction

Net shares sold 2,450 shares netBuySellShares for this Form 4

Key Terms

open-market sale, Common Stock, transaction_code, net-sell

4 terms

open-market sale financial

"transaction_action: "open-market sale" for 2,450 common shares"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Common Stock financial

"security_title: "Common Stock" for the reported transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

transaction_code financial

"transaction_code: "S" indicating a sale in open market"

net-sell financial

"netBuySellDirection is labeled as "net-sell" in the summary"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did USANA (USNA) disclose for John Turman Fleming?

USANA Health Sciences reported that director John Turman Fleming sold 2,450 shares of common stock in an open-market transaction. The trade was recorded on a Form 4 and classified as a sale in the open market at a disclosed per-share price.

How many USANA (USNA) shares did the director sell and at what price?

John Turman Fleming sold 2,450 shares of USANA common stock at a price of $17.93 per share. This was an open-market sale, meaning the shares were sold through normal trading on the market rather than via a private or structured transaction.

How many USANA (USNA) shares does John Turman Fleming hold after the sale?

After the reported transaction, John Turman Fleming directly holds 4,230 shares of USANA common stock. This figure reflects his ownership immediately following the 2,450-share open-market sale disclosed in the Form 4 insider trading report.

Was the USANA (USNA) insider trade classified as an open-market sale?

Yes. The transaction for John Turman Fleming is coded as an open-market sale, meaning the shares were sold in regular market trading. The Form 4 specifically labels the action as an open-market sale of common stock rather than a grant, gift, or tax withholding event.

Did USANA (USNA) report any options or derivative exercises in this Form 4?

No derivative transactions are listed in this Form 4. The filing shows only a non-derivative transaction involving common stock, with 2,450 shares sold. The derivativeSummary section is empty, indicating no options or similar instruments are reported in this particular filing.

Is the USANA (USNA) director’s transaction a net buy or net sell event?

The transaction is a net sell event. The Form 4 summary shows 2,450 shares sold and zero shares bought, resulting in netBuySellShares of -2,450 and a netBuySellDirection labeled as "net-sell" for this reporting period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/01/2026 - 04:36 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fleming John Turman

(Last) (First) (Middle)

3838 WEST PARKWAY BLVD.

(Street)

SALT LAKE CITY UTAH 84120

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/01/2026		S		2,450	D	$17.93	4,230	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Joshua Foukas, Attorney-in-Fact	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)